380 related articles for article (PubMed ID: 2904568)
21. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
[TBL] [Abstract][Full Text] [Related]
22. Eradication of Campylobacter pylori and recurrence of duodenal ulcer. A six-month follow-up study.
Mouzas IA; Kalantzis N; Gabriel P; Kallimanis G; Papantoniou P; Mavrogiannis H
Acta Gastroenterol Latinoam; 1990; 20(3):159-61. PubMed ID: 2095099
[TBL] [Abstract][Full Text] [Related]
23. Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
Lambert JR; McLean AJ
Med J Aust; 1989 Aug; 151(3):120-2. PubMed ID: 2755371
[No Abstract] [Full Text] [Related]
24. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
Pan SA; Liao CH; Lien GS; Chen SH
Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788
[TBL] [Abstract][Full Text] [Related]
25. Dosage of colloidal bismuth subcitrate in duodenal ulcer healing and clearance of Campylobacter pylori.
Coghlan J; Hutchinson L; Gilligan D; McKenna D; Keane C; Sweeney E; O'Morain C
Aliment Pharmacol Ther; 1990 Feb; 4(1):49-54. PubMed ID: 2104073
[TBL] [Abstract][Full Text] [Related]
26. Cure of duodenal ulcer after eradication of Helicobacter pylori.
George LL; Borody TJ; Andrews P; Devine M; Moore-Jones D; Walton M; Brandl S
Med J Aust; 1990 Aug; 153(3):145-9. PubMed ID: 1974027
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
[TBL] [Abstract][Full Text] [Related]
28. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
30. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.
Glupczynski Y; Burette A; Nyst JF; De Prez C; De Koster E; Deltenre M
Acta Gastroenterol Belg; 1988; 51(4-5):329-37. PubMed ID: 2979039
[TBL] [Abstract][Full Text] [Related]
31. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
[No Abstract] [Full Text] [Related]
32. Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.
Ho J; Hui WM; Ng I; Lam SK
Aliment Pharmacol Ther; 1989 Jun; 3(3):315-20. PubMed ID: 2577695
[TBL] [Abstract][Full Text] [Related]
33. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
[TBL] [Abstract][Full Text] [Related]
34. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
35. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
Miller JP; Faragher EB
Scand J Gastroenterol Suppl; 1989; 160():39-45. PubMed ID: 2573145
[TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
J Formos Med Assoc; 1993 Aug; 92(8):721-4. PubMed ID: 7904847
[TBL] [Abstract][Full Text] [Related]
37. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
38. Duodenal ulcer relapse after eradication of Campylobacter pylori.
Lam SK
Lancet; 1989 Feb; 1(8634):384. PubMed ID: 2563535
[No Abstract] [Full Text] [Related]
39. [Ulcer symptoms without demonstration of ulcer: causative therapy with demonstration of Helicobacter pylori].
Kobler E; Müller B; Wüst W
Schweiz Rundsch Med Prax; 1990 Mar; 79(13):398-9. PubMed ID: 2320815
[TBL] [Abstract][Full Text] [Related]
40. Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study.
Huang CK; Chen GH
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):15-20. PubMed ID: 8364776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
